NCT03712163View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

February 18, 2019

Study Completion Date

March 14, 2019

Conditions
Healthy Subjects
Interventions
DRUG

Norketotifen Oral Capsule (Cohort 1)

Single dose Norketotifen

DRUG

Norketotifen Oral Capsule (Cohort 2)

Single dose Norketotifen

DRUG

Norketotifen Oral Capsule (Cohort 3)

Single dose Norketotifen

DRUG

Norketotifen Oral Capsule (Multiple Dose Cohort)

Multiple dose Norketotifen

DRUG

Placebo Oral Capsule

Placebo

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors
All Listed Sponsors
lead

Emergo Therapeutics, Inc.

INDUSTRY